Target (CBDY) Assets Average (2014 - 2026)
Target (CBDY) reported Assets Average of $6.1 million for Q1 2026, down 13.98% year-over-year from $7.1 million in Q1 2025, and down 0.98% quarter-over-quarter from $6.2 million in Q4 2025.
Target (CBDY) Assets Average (2014 - 2026) Analysis & Trends
Target (CBDY) has 13 years of Assets Average data on file, last reported at $6.1 million in Q1 2026.
- Assets Average for Q1 2026 came in at $6.1 million, down 13.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.1 million (down 13.98% YoY), and the FY2025 annual result was $6.9 million, down 16.23% from the prior year.
- Assets Average slipped to $6.1 million in Q1 2026 per CBDY's latest filing, from $6.2 million in the prior quarter.
- Over five years, Assets Average peaked at $12.3 million in Q2 2022 and troughed at $6.1 million in Q1 2026.
- A 5-year average of $8.0 million and a median of $7.7 million in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2023 and 2024: Assets Average plunged 32.24% in 2023, then retreated 10.19% in 2024.
- A 5-year view of Assets Average shows it stood at $11.0 million in 2022, then decreased by 21.97% to $8.6 million in 2023, then retreated by 11.7% to $7.6 million in 2024, then declined by 18.37% to $6.2 million in 2025, then fell by 0.98% to $6.1 million in 2026.
- Business Quant data shows CBDY's Assets Average at $6.1 million in Q1 2026, $6.2 million in Q4 2025, and $6.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 40.39 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 15.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 7.30 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 552.96 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4.77 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.29 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 3.37 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 2.21 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.29 Bn |
| 10 | Target | - | - | 191,787.00 | 6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.13 Mn |
| Dec 31, 2025 | 6.19 Mn |
| Sep 30, 2025 | 6.39 Mn |
| Jun 30, 2025 | 6.63 Mn |
| Mar 31, 2025 | 7.12 Mn |
| Dec 31, 2024 | 7.58 Mn |
| Sep 30, 2024 | 7.76 Mn |
| Jun 30, 2024 | 7.50 Mn |
| Mar 31, 2024 | 7.96 Mn |
| Dec 31, 2023 | 8.58 Mn |
| Sep 30, 2023 | 8.67 Mn |
| Jun 30, 2023 | 8.36 Mn |
| Sep 30, 2022 | 11.00 Mn |
| Jun 30, 2022 | 12.33 Mn |
| Sep 30, 2021 | 13.26 Mn |
| Jun 30, 2021 | 13.74 Mn |
| Mar 31, 2021 | 13.46 Mn |
| Dec 31, 2020 | 15.14 Mn |
| Sep 30, 2020 | 16.53 Mn |
| Jun 30, 2020 | 15.46 Mn |